Novartis Products Evaluation, 1997

نویسندگان
چکیده

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Lumiracoxib (Novartis).

Lumiracoxib, an inhibitor of cyclooxygenase 2 (COX-2), is under development by Novartis for the potential treatment of osteoarthritis, rheumatoid arthritis and pain. By late December 2000, phase III trials had been initiated and were ongoing in December 2001.

متن کامل

Fingolimod. Mitsubishi Pharma/Novartis.

Mitsubishi Pharma Corp and Novartis AG are developing fingolimod, an orally active immunosuppressant affecting lymphocyte re-circulation, for the potential prevention of transplant rejection and the treatment of autoimmune diseases, including multiple sclerosis. Fingolimodis a synthetic sphingosine analog that becomes phosphorylated in vivo and acts as a sphingosine-1-phosphate receptor agonist.

متن کامل

The Novartis Foundation

before — a hotbed of gene therapy research. It was a remarkable opportunity. Mulligan was offered one laboratory at the Children's Hospital to work on the basic science of viral vectors, and a second laboratory in a central Harvard building that will manufacture the vectors for use in human trials. Despite all these enticements, Mulligan did not agree to move — and leave a position at the White...

متن کامل

Novartis CSR template

Study center(s): A total of 2957 centers in 27 countries enrolled at least one patient (number of centers in brackets): Argentina (15), Austria (22), Bahrain (9), Belgium (335), Bulgaria (24), Colombia (25), Czech Republic (39), Ecuador (3), Germany (790), Greece (7), India (472), Jordan (26), Republic of Korea (54), Kuwait (13), Lebanon (53), Luxembourg (2), Mexico (264), Netherlands (129), Om...

متن کامل

[Cytotoxicity of chemicals used in household products: 1997- 2004].

The cytotoxicities of chemicals used in household products were evaluated using a neutral red (NR) uptake assay. The chemicals tested during 1997-2004 were rubber additives (accelerators, antioxidants and retarders), solvents, plasticizers and biocides, such as antimicrobials, fungicides, preservatives used in paints, paper, wood and plastic products. The cytotoxicity potential of each chemical...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: Arthropod Management Tests

سال: 1998

ISSN: 2155-9856

DOI: 10.1093/amt/23.1.4